Moreover, the effects induced by KD of candidates including SHC1, VEGFC, VEGFR3, and ERK1/2 were evaluated by cell proliferation assay, displaying SHC1 as the strongest inhibitor of bladder cancer proliferation (Fig. 4c). The gene discussed is FLT4; the disease is urinary bladder carcinoma.